$RNA 4 SEC Filings

Filed On	Filing
22 Sep 2026	Form 4: Younis Husam, Chief Scientific Officer Gave up 11,216 shares to cover exercise price or tax ($100K)
22 Sep 2026	Form 4: Hughes Steven George, Chief Medical Officer Gave up 21,459 shares to cover exercise price or tax ($192K)
22 Sep 2026	Form 4: Flanagan W. Michael, Director Gave up 22,812 shares to cover exercise price or tax ($204K)
22 Sep 2026	Form 4: Boyce Sarah, Director Gave up 126,418 shares to cover exercise price or tax ($1.13M)
22 Sep 2026	Form 4: Kenney Stephanie, See Remarks Gave up 2,375 shares to cover exercise price or tax ($21.3K)
22 Sep 2026	Form 4: Gallagher Kathleen P., Director Gave up 11,632 shares to cover exercise price or tax ($104K)
22 Sep 2026	Form 4: Winslow Brendan R., Chief Financial Officer Gave up 6,742 shares to cover exercise price or tax ($60.3K)
22 Sep 2026	Form 4: Hoyos Rocio Martin, Chief Strategy Officer Gave up 8,320 shares to cover exercise price or tax ($74.5K)
22 Apr 2026	Form 4: Kenney Stephanie, See Remarks Received 30,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)
22 Apr 2026	Form 4: Hughes Steven George, Chief Medical Officer Received 30,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)
22 Apr 2026	Form 4: Winslow Brendan R., Chief Financial Officer Received 30,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)
22 Apr 2026	Form 4: Gallagher Kathleen P., Director Received 102,500 shares as a grant or award · Granted 205,000 Stock Option (Right to Buy)
22 Apr 2026	Form 4: Hoyos Rocio Martin, Chief Strategy Officer Received 30,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)
22 Apr 2026	Form 4: Younis Husam, Chief Scientific Officer Received 30,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Skerjanec Simona, Director Granted 20,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Boyce Sarah, Director Granted 20,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Boess Carsten, Director Granted 20,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Wilson Troy Edward, Director Granted 20,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Flanagan W. Michael, Director Granted 20,000 Stock Option (Right to Buy)

Comments